107 related articles for article (PubMed ID: 11563821)
1. Human umbilical cord blood cells ameliorate Alzheimer's disease in transgenic mice.
Ende N; Chen R; Ende-Harris D
J Med; 2001; 32(3-4):241-7. PubMed ID: 11563821
[TBL] [Abstract][Full Text] [Related]
2. Parkinson's disease mice and human umbilical cord blood.
Ende N; Chen R
J Med; 2002; 33(1-4):173-80. PubMed ID: 12939116
[TBL] [Abstract][Full Text] [Related]
3. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice.
Chen R; Ende N
J Med; 2000; 31(1-2):21-30. PubMed ID: 10998753
[TBL] [Abstract][Full Text] [Related]
4. Human umbilical cord blood cells ameliorate Huntington's disease in transgenic mice.
Ende N; Chen R
J Med; 2001; 32(3-4):231-40. PubMed ID: 11563820
[TBL] [Abstract][Full Text] [Related]
5. NOD/LtJ type I diabetes in mice and the effect of stem cells (Berashis) derived from human umbilical cord blood.
Ende N; Chen R; Mack R
J Med; 2002; 33(1-4):181-7. PubMed ID: 12939117
[TBL] [Abstract][Full Text] [Related]
6. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
[TBL] [Abstract][Full Text] [Related]
7. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
[TBL] [Abstract][Full Text] [Related]
8. Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice.
Ozmen L; Albientz A; Czech C; Jacobsen H
Neurodegener Dis; 2009; 6(1-2):29-36. PubMed ID: 19066434
[TBL] [Abstract][Full Text] [Related]
9. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.
Lafay-Chebassier C; Paccalin M; Page G; Barc-Pain S; Perault-Pochat MC; Gil R; Pradier L; Hugon J
J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364
[TBL] [Abstract][Full Text] [Related]
10. Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice.
Hartmann J; Erb C; Ebert U; Baumann KH; Popp A; König G; Klein J
Neuroscience; 2004; 125(4):1009-17. PubMed ID: 15120860
[TBL] [Abstract][Full Text] [Related]
11. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent.
Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S
Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807
[TBL] [Abstract][Full Text] [Related]
12. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
13. Noggin and BMP4 co-modulate adult hippocampal neurogenesis in the APP(swe)/PS1(DeltaE9) transgenic mouse model of Alzheimer's disease.
Tang J; Song M; Wang Y; Fan X; Xu H; Bai Y
Biochem Biophys Res Commun; 2009 Jul; 385(3):341-5. PubMed ID: 19463786
[TBL] [Abstract][Full Text] [Related]
14. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
[TBL] [Abstract][Full Text] [Related]
15. An in vitro and in vivo study of early deficits in associative learning in transgenic mice that over-express a mutant form of human APP associated with Alzheimer's disease.
Domínguez-del-Toro E; Rodríguez-Moreno A; Porras-García E; Sánchez-Campusano R; Blanchard V; Laville M; Böhme GA; Benavides J; Delgado-García JM
Eur J Neurosci; 2004 Oct; 20(7):1945-52. PubMed ID: 15380017
[TBL] [Abstract][Full Text] [Related]
16. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
[TBL] [Abstract][Full Text] [Related]
17. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).
Crawford FC; Wood M; Ferguson S; Mathura VS; Faza B; Wilson S; Fan T; O'Steen B; Ait-Ghezala G; Hayes R; Mullan MJ
Brain Res; 2007 Dec; 1185():45-58. PubMed ID: 17961517
[TBL] [Abstract][Full Text] [Related]
18. A decade of modeling Alzheimer's disease in transgenic mice.
McGowan E; Eriksen J; Hutton M
Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
[TBL] [Abstract][Full Text] [Related]
19. Learning and memory in transgenic mice modeling Alzheimer's disease.
Ashe KH
Learn Mem; 2001; 8(6):301-8. PubMed ID: 11773429
[TBL] [Abstract][Full Text] [Related]
20. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E
Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
